Dr. Loren Scott Michel on HPV-Associated Oropharyngeal Cancer

Loren Scott Michel, MD
Published: Wednesday, Apr 01, 2015

Loren Scott Michel, MD, Assistant Professor Medicine, Washington University, medical oncologist Siteman Cancer Center, discusses the link between human papillomavirus (HPV) and oropharyngeal cancers.

HPV-associated oropharyngeal cancer is a growing public health concern, Michel says. He estimates that there are approximately 10,000-12,000 cases of HPV-associated oropharyngeal cancer per year in the United States and that number is rising throughout the western world.

However, HPV-associated cancers are often easier to treat than HPV-negative, Michel says. Multiple studies show approximately 85% long- term survival for HPV-associated cancers, versus the average of 55% long term survival for HPV negative oropharyngeal disease.

Loren Scott Michel, MD, Assistant Professor Medicine, Washington University, medical oncologist Siteman Cancer Center, discusses the link between human papillomavirus (HPV) and oropharyngeal cancers.

HPV-associated oropharyngeal cancer is a growing public health concern, Michel says. He estimates that there are approximately 10,000-12,000 cases of HPV-associated oropharyngeal cancer per year in the United States and that number is rising throughout the western world.

However, HPV-associated cancers are often easier to treat than HPV-negative, Michel says. Multiple studies show approximately 85% long- term survival for HPV-associated cancers, versus the average of 55% long term survival for HPV negative oropharyngeal disease.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x